• Amgen's leukemia drug one of world's priciest Wednesday, 17 Dec 2014 | 7:26 PM ET
    Amgen building in South San Francisco, California.

    Amgen's new leukemia drug Blincyto costs $178,000 for two courses of the treatment.

  • Colorado funds medical marijuana research, a first Wednesday, 17 Dec 2014 | 6:01 AM ET

    DENVER— Colorado was poised Wednesday to award more than $8 million for medical marijuana research, a step toward addressing complaints that little is known about pot's medical potential. That's because the Colorado grants are outside the usual federal channels for approving studies on pot, a process some say stymies marijuana research.

  • Magic mushrooms found in the queen's garden Friday, 12 Dec 2014 | 10:52 AM ET

    Hallucinogenic mushrooms have been discovered on the grounds of Buckingham Palace in London, NBC News reports.

  • Gilead sued over 'exorbitant' hepatitis C drug prices Wednesday, 10 Dec 2014 | 3:55 PM ET

    Dec 10- Philadelphia's transportation authority has filed a class action lawsuit accusing Gilead Sciences Inc of charging "exorbitant" prices for its blockbuster hepatitis C drug Sovaldi. The lawsuit, filed Tuesday in federal court in Philadelphia by the Southeastern Pennsylvania Transportation Authority, seeks an unspecified amount of money damages.

  • Paid doctor consultants swayed to use pricey drugs? Monday, 8 Dec 2014 | 11:11 AM ET
    Lucentis, produced by Genetech.

    Doctors who used Genentech's expensive eye drug Lucentis were also among the highest-paid consultants for the company, reports the New York Times.

  • Cubist Pharm's shares soar on BIG Merck deal Monday, 8 Dec 2014 | 7:59 AM ET
    A researcher at a Cubist Pharmaceuticals lab.

    Drug giant Merck said it will buy Cubist and its slate of medicines administered in hospitals, many for bacterial infections, for about $9.5 billion.

  • Second-smartest man takes 38 types of pills Wednesday, 3 Dec 2014 | 7:20 PM ET

    The second smartest man in the world takes about 38 types of drugs everyday in order to maintain his mental and physical well being.

  • Searching for relief from expensive generic drugs Tuesday, 25 Nov 2014 | 2:24 PM ET
    Senator Amy Klobuchar

    Generic drug costs have risen so much that some drugs have surpassed their equivalents in other developed countries, the New York Times reports.

  • Silver economy: How to invest in an aging population Monday, 24 Nov 2014 | 5:48 AM ET

    There is no escaping the fact that we’re all getting older, and investors are having to find new ways to make money from changes in the way we age.

  • Bob Marley to headline corporate cannabis brand Tuesday, 18 Nov 2014 | 5:38 PM ET
    Bob Marley, circa 1976

    Bob Marley heirs say they are creating a pot-focused brand dubbed Marley Natural, reports NBC News.

  • DEA painkiller probe targets NFL medical staffs Monday, 17 Nov 2014 | 11:46 AM ET
    Joe Horn

    DEA agents questioned medical-staff members from several NFL teams in a continuing investigation into distribution of painkillers, The NYT reports.

  • Global agencies swoop on 'dark markets' using Tor Friday, 7 Nov 2014 | 7:56 AM ET

    Law enforcement agencies around the globe undertook action against so-called "dark markets" running anonymously on the "Tor" network, on Thursday.

  • Sex & drug claims at Jefferies draw a risky retort Tuesday, 4 Nov 2014 | 7:38 AM ET

    Two Jefferies executives marched with other company bankers to take drug tests in solidarity with Sage Kelly, reports the New York Times.

  • Heroin addiction: Needles now a currency in Myanmar Tuesday, 28 Oct 2014 | 10:56 PM ET

    Along the Myanmar-China border, where heroin addiction is common, fresh needles are now so coveted that shopkeepers dispense them as change.

  • Sex, drugs and biotechs in nasty divorce case Tuesday, 28 Oct 2014 | 1:33 PM ET
    Screen shot of Marc Beer on CNBC

    A nasty Wall Street divorce has touched two biotech CEOs and appears to have moved their company stocks down over drug use allegations.

  • What's boosting healthiest sector in S&P this year Monday, 27 Oct 2014 | 1:43 PM ET

    Health care has been on a tear in 2014, and there is still room for upside. Wall Street analysts are focusing on the following four trends.

  • Investors see generous profits in obesity epidemic Monday, 27 Oct 2014 | 9:42 AM ET

    With some 84 million people in the U.S. struggling with obesity, investing in obesity stocks has become a Wall Street trend.

  • US spent $7.6B against Afghan poppy...to no avail Wednesday, 22 Oct 2014 | 2:36 PM ET
    An Afghan policeman destroys poppies during a campaign against narcotics in Kunar province, April 29, 2014.

    Although the US spent $7.6 billion to eradicate poppy in Afghanistan, cultivation of the opium source is at an all time high.

  • GSK revenue disappoints with 3% fall to $8.9B Wednesday, 22 Oct 2014 | 7:22 AM ET

    GlaxoSmithKline (GSK) reported third-quarter revenue lower than analysts forecast, as sales of blockbuster asthma drug Advair continued to fall.

  • LONDON, Oct 21- Sales growth at consumer goods maker Reckitt Benckiser slowed more sharply than expected in the third quarter, hit by sluggish Western economies and cooling emerging markets. "Growth has not yet returned to developed markets and emerging markets in aggregate are weaker," Chief Executive Rakesh Kapoor said, citing places such as Thailand,...